Why is Shenzhen New Industries Biomedical Engineering Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 16.47% and Operating profit at 15.07% over the last 5 years
2
Negative results in Mar 25
- INTEREST(HY) At CNY 0.21 MM has Grown at 21.1%
- DEBT-EQUITY RATIO (HY) Highest at -27.48 %
- OPERATING PROFIT MARGIN(Q) Lowest at 40.87 %
3
With ROE of 20.16%, it has a expensive valuation with a 5.58 Price to Book Value
- Over the past year, while the stock has generated a return of -5.03%, its profits have fallen by -6.5%
- At the current price, the company has a high dividend yield of 2.2
4
Underperformed the market in the last 1 year
- Even though the market (China Shanghai Composite) has generated returns of 15.18% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -5.03% returns
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Shenzhen New Industries Biomedical Engineering Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Shenzhen New Industries Biomedical Engineering Co., Ltd.
-13.07%
-0.40
32.61%
China Shanghai Composite
14.77%
1.01
15.10%
Quality key factors
Factor
Value
Sales Growth (5y)
16.47%
EBIT Growth (5y)
15.07%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.28
Sales to Capital Employed (avg)
0.52
Tax Ratio
12.50%
Dividend Payout Ratio
55.86%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
40.76%
ROE (avg)
19.99%
Valuation Key Factors 
Factor
Value
P/E Ratio
28
Industry P/E
Price to Book Value
5.58
EV to EBIT
25.64
EV to EBITDA
22.63
EV to Capital Employed
6.82
EV to Sales
9.88
PEG Ratio
NA
Dividend Yield
2.20%
ROCE (Latest)
26.62%
ROE (Latest)
20.16%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Movement
1What is working for the Company
INVENTORY TURNOVER RATIO(HY)
Highest at 1.41%
-9What is not working for the Company
INTEREST(HY)
At CNY 0.21 MM has Grown at 21.1%
DEBT-EQUITY RATIO
(HY)
Highest at -27.48 %
OPERATING PROFIT MARGIN(Q)
Lowest at 40.87 %
OPERATING PROFIT(Q)
Lowest at CNY 456.16 MM
Here's what is working for Shenzhen New Industries Biomedical Engineering Co., Ltd.
Inventory Turnover Ratio
Highest at 1.41%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Here's what is not working for Shenzhen New Industries Biomedical Engineering Co., Ltd.
Interest
At CNY 0.21 MM has Grown at 21.1%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Operating Profit Margin
Lowest at 40.87 % and Fallen
In each period in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Debt-Equity Ratio
Highest at -27.48 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Operating Profit
Lowest at CNY 456.16 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)






